Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function
Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Purpose
Peptide receptor radionuclide therapy (PRRT) with radiolabelled somatostatin analogues is a novel therapy for patients with somatostatin receptor-positive tumours. We determined the effects of PRRT with [
177
Lu-DOTA
0
,Tyr
3
]octreotate (
177
Lu-octreotate) on glucose homeostasis and the pituitary-gonadal, pituit...
Alternative Titles
Full title
Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2764054
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2764054
Other Identifiers
ISSN
1619-7070
E-ISSN
1619-7089
DOI
10.1007/s00259-009-1151-8
